BRAND_ANALYSIS #PFIZER HEALTH & PHARMA #24 OF 26 IN HEALTH & PHARMA ALIGNED

Pfizer

· Public · Updated 22 Nov 2026 07:19 UTC
#1107 of 1208 overall by tension · #24 of 26 in Health & Pharma
7 Aligned
The Balanced
Analysis

Pfizer holds C50 / B57 with an 8.61 percent stock fall, a pharmaceutical giant whose cultural reputation still carries pandemic-era baggage. The business is sturdy but the public story is unresolved. Tension remains modest, which says the company is less fought over than it used to be.

IN THE NEWS (100 articles this week)
Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna - Fierce Biotech
Pfizer licenses CAR-T therapies from China's Starna in up to $2.6 billion deal - Reuters
Pfizer Inc. - Britannica
Cultural Score
50 / 100
Business Score
57 / 100
TENSION▂▂▂▂▁▂▂▂▂▂▂▂▂▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▅▅▅▄▅▅▅▆▆▆▅▅▄
Loading...
Wikipedia Momentum 15/40
News Presence 36/35
Search InterestRedistributed to other dimensions
Stock Momentum 12/30
Market Position 22/25
Revenue Growth 11/25
Earnings Health 12/20
Price$27.40
30d Change-8.6%
Market Cap$156.2B
Profit Margin6.3%
Pfizer's tension is 7. Commerce outpacing culture. sociologyofcapitalism.com/brand/pfizer
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/pfizer.html" width="320" height="200" frameborder="0"></iframe>